Predictors of Significant Disease Activity Score-28 (Using C-reactive protein) Remission Achieved with Intravenous Golimumab in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of the Phase 3, Multicenter, Double-Blind, Placebo-Controlled Trial

被引：0
|
作者：
Bingham, Clifton O., III [1 ]
Weinblatt, Michael [2 ]
Mendelsohn, Alan [3 ]
Kim, Lilianne [3 ]
Mack, Michael [3 ]
Lu, Jiandong [3 ]
Baker, Daniel [3 ]
Westhovens, Rene [4 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Janssen Res & Dev LLC, Spring House, PA USA
[4] Univ Hosp KU Leuven, Louvain, Belgium
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1301
引用
收藏
页码：S558 / S558
页数：1
相关论文
共 50 条
  • [21] USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS OF THE PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PSUMMIT I STUDY
    McInnes, I. B.
    Kavanaugh, A.
    Gottlieb, A. B.
    Puig, L.
    Rahman, P.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Mendelsohn, A. M.
    Doyle, M. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 107 - 107
  • [22] Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study (vol 58, pg 964, 2008)
    Kay
    ARTHRITIS AND RHEUMATISM, 2010, 62 (11): : 3518 - 3518
  • [23] One-year results of golimumab compared with placebo in patients with active RA despite treatment with methotrexate: A phase II, randomized, double-blind, placebo-controlled, dose-ranging trial.
    Kay, J.
    Matteson, E. L.
    Dasgupta, B.
    Nash, P.
    Durez, P.
    Hall, S.
    Hsia, E. C.
    Chiruvolu, P.
    Han, J.
    Rahman, M. U.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S833 - S833
  • [24] RESULTS FROM A MULTICENTER, INTERNATIONAL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF SIRUKUMAB, A HUMAN ANTI-IL-6 MONOCLONAL ANTIBODY, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY
    Hsu, B.
    Sheng, S.
    Weinblatt, M. E.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 61 - 61
  • [25] Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial
    Mease, Philip
    Husni, M. Elaine
    Kafka, Shelly
    Chakravarty, Soumya D.
    Harrison, Diane D.
    Lo, Kim Hung
    Xu, Stephen
    Hsia, Elizabeth C.
    Kavanaugh, Arthur
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [26] Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial
    Philip Mease
    M. Elaine Husni
    Shelly Kafka
    Soumya D. Chakravarty
    Diane D. Harrison
    Kim Hung Lo
    Stephen Xu
    Elizabeth C. Hsia
    Arthur Kavanaugh
    Arthritis Research & Therapy, 22
  • [27] EFFICACY AND SAFETY OF LEVILIMAB IN COMBINATION WITH METHOTREXATE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: 1-YEAR RESULTS OF PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL
    Mazurov, V.
    Korolev, M.
    Pristrom, A.
    Kundzer, A.
    Soroka, N.
    Kastanayan, A.
    Povarova, T.
    Plaksina, T.
    Antipova, O.
    Kretchikova, D.
    Smakotina, S.
    Tciupa, O.
    Puntus, E.
    Raskina, T.
    Shilova, L.
    Kropotina, T.
    Nesmeyanova, O.
    Popova, T.
    Vinogradova, I.
    Linkova, I.
    Plotnikova, A.
    Pukhtinskaia, P.
    Zinkina-Orikhan, A.
    Eremeeva, A.
    Lutckii, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 596 - 596
  • [28] INTRAVENOUS GOLIMUMAB INHIBITS RADIOGRAPHIC PROGRESSION AND MAINTAINS CLINICAL EFFICACY AND SAFETY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY: 2-YEAR RESULTS OF A PHASE 3 TRIAL OF INTRAVENOUS GOLIMUMAB
    Weinblatt, M. E.
    Bingham, C. O., III
    Mendelsohn, A. M.
    Kim, L.
    Lo, K. H.
    Noonan, L.
    Baker, D.
    Westhovens, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 939 - 939
  • [29] Results From a Multicenter, International, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Sirukumab, a Human Anti-IL-6 Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy.
    Hsu, Benjamin
    Sheng, Shihong
    Weinblatt, Michael E.
    Smolen, Josef
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S1035 - S1035
  • [30] UTILITY OF VECTRA-DA™ ON ASSESSMENT OF RHEUMATOID ARTHRITIS DISEASE ACTIVITY AND GOLIMUMAB RESPONSE: RESULTS OF A PILOT STUDY FROM A PHASE 3 TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY
    Lamberth, S.
    Cherkas, Y.
    Brodmerkel, C.
    Curran, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 581 - 582
12345